The FDA Could, Finally, Approve Novavax's Covid Vaccine — Is Novavax Stock A Buy?Investors Business Daily • 07/19/24
Novavax, Inc. (NVAX) is Attracting Investor Attention: Here is What You Should KnowZacks Investment Research • 07/16/24
Wall Street Bulls Look Optimistic About Novavax (NVAX): Should You Buy?Zacks Investment Research • 07/15/24
Novavax (NVAX) Falls More Steeply Than Broader Market: What Investors Need to KnowZacks Investment Research • 06/28/24
Meme Stock or Vaccine Stock? Novavax's Identity Crisis and Why It Matters for InvestorsInvestorPlace • 06/28/24
Novavax, Inc. (NVAX) Is a Trending Stock: Facts to Know Before Betting on ItZacks Investment Research • 06/24/24
Novavax Submits Application to European Medicines Agency for Updated Protein-based 2024-2025 Formula COVID-19 VaccinePRNewsWire • 06/24/24
Novavax Submits Application to U.S. FDA for Updated Protein-based 2024-2025 Formula COVID-19 VaccinePRNewsWire • 06/14/24
Investors Heavily Search Novavax, Inc. (NVAX): Here is What You Need to KnowZacks Investment Research • 06/10/24